Potentiation of Glucocorticoid Activity by 5β-Dihydrocortisol: Its Role in Glaucoma
Authors:
- 14 October 1983
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 222 (4620) , 172-173
Abstract
5β-Dihydrocortisol potentiated the threshold level (the smallest dose producing a measurable effect) of topically applied cortisol (0.02 percent) and dexamethasone (0.003 percent) in causing nuclear translocation of the cytosolic glucocorticoid receptor in rabbit iris-ciliary body tissue. 5β-Dihydrocortisol accumulates in cells cultured from trabecular meshwork specimens from patients with primary open-angle glaucoma, but not in similar cells derived from nonglaucomatous patients. In view of the sensitivity of patients with primary open-angle glaucoma to the effects of glucocorticoids in raising intraocular pressure, this potentiation may be responsible for the steroid sensitivity and for the ocular hypertension seen in this disorder.Keywords
This publication has 3 references indexed in Scilit:
- Dihydrocortisol: A potential mineralocorticoidThe Journal of Steroid Biochemistry and Molecular Biology, 1978
- Effect of Corticosteroids on Intraocular Pressure and Fluid DynamicsArchives of Ophthalmology (1950), 1963
- Corticosteroids and Intraocular PressureArchives of Ophthalmology (1950), 1963